GH-IGF1 Axis in Children with Cystic Fibrosis

Sara Pagani, Elena Bozzola, Gloria Acquafredda, Vito Terlizzi, Valeria Raia, Fabio Majo, Alberto Villani, Mauro Bozzola

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To verify whether growth hormone receptor gene expression plays a role in Cystic fibrosis (CF)children's growth, as a consequence of the chronic inflammatory condition and malnutrition.

DESIGN: We enrolled forty-nine prepubertal patients (24 males and 25 females) affected by CF in a stable clinical condition, 19 of whom had been diagnosed through newborn screening and 30 following presentation of symptoms. Patients had no significant comorbidity affecting growth or CFTR (Cystic Fibrosis Transmembrane conductance Regulator)-related diabetes requiring insulin therapy. Blood was collected during two follow-up visits to measure IGF-I, GHBP and GH-R gene expression. Fifty-two healthy children, sex- and age-matched, were recruited as a control group.

METHODS: In this study we compared BMI, height, weight, IGF-I, GHBP and GHR gene expression values (evaluated by Chemiluminescent Immunometric assay; ELISA and Real time PCR respectively) in CF patients diagnosed through NBS (New born screening), or by symptoms (Late Diagnosis (LD)) and in healthy controls.

RESULTS: BMI increased significantly in patients between the time of diagnosis and check-ups (p<0.001) and particularly in the LD group, the median value was lower at diagnosis and significantly higher (p<0.001) at follow up visits compared to controls. At the initial evaluation, higher levels of IGF-I (not statistically significant) were found in both the NBS group and in the LD group compared to the control group. At the second evaluation, significantly higher levels of IGF-I (p=0.003) were found in both the NBS and LD groups compared to controls; GHR mRNA expression had significantly increased (p=0.013) in LD patients in comparison with the first evaluation and was significantly higher in the NBS and LD groups than in controls. GHBP values had significantly increased (p=0.047) in the NBS group after one year of therapy compared to first visit levels and were significantly higher (p<0,0001) in the NBS and LD groups compared to controls.

CONCLUSION: In our LD patients during childhood, we observed good auxological values and a GH/IGF-I axis function within normal range for the factor evaluated. However, earlier diagnosis through NBS might further minimize and prevent growth retardation, by reducing the duration of symptoms before treatment.

Original languageEnglish
JournalClinical Medicine and Research
DOIs
Publication statusE-pub ahead of print - Aug 28 2019

Fingerprint

Delayed Diagnosis
Cystic Fibrosis
Insulin-Like Growth Factor I
Gene Expression
Control Groups
Growth
Luminescent Measurements
vpr Genes
Somatotropin Receptors
Cystic Fibrosis Transmembrane Conductance Regulator
Malnutrition
Comorbidity
Real-Time Polymerase Chain Reaction
Early Diagnosis
Reference Values
Therapeutics
Enzyme-Linked Immunosorbent Assay
Newborn Infant
Insulin
Weights and Measures

Cite this

GH-IGF1 Axis in Children with Cystic Fibrosis. / Pagani, Sara; Bozzola, Elena; Acquafredda, Gloria; Terlizzi, Vito; Raia, Valeria; Majo, Fabio; Villani, Alberto; Bozzola, Mauro.

In: Clinical Medicine and Research, 28.08.2019.

Research output: Contribution to journalArticle

@article{3d311d9a98a3482b9c775b5a880bed4b,
title = "GH-IGF1 Axis in Children with Cystic Fibrosis",
abstract = "OBJECTIVE: To verify whether growth hormone receptor gene expression plays a role in Cystic fibrosis (CF)children's growth, as a consequence of the chronic inflammatory condition and malnutrition.DESIGN: We enrolled forty-nine prepubertal patients (24 males and 25 females) affected by CF in a stable clinical condition, 19 of whom had been diagnosed through newborn screening and 30 following presentation of symptoms. Patients had no significant comorbidity affecting growth or CFTR (Cystic Fibrosis Transmembrane conductance Regulator)-related diabetes requiring insulin therapy. Blood was collected during two follow-up visits to measure IGF-I, GHBP and GH-R gene expression. Fifty-two healthy children, sex- and age-matched, were recruited as a control group.METHODS: In this study we compared BMI, height, weight, IGF-I, GHBP and GHR gene expression values (evaluated by Chemiluminescent Immunometric assay; ELISA and Real time PCR respectively) in CF patients diagnosed through NBS (New born screening), or by symptoms (Late Diagnosis (LD)) and in healthy controls.RESULTS: BMI increased significantly in patients between the time of diagnosis and check-ups (p<0.001) and particularly in the LD group, the median value was lower at diagnosis and significantly higher (p<0.001) at follow up visits compared to controls. At the initial evaluation, higher levels of IGF-I (not statistically significant) were found in both the NBS group and in the LD group compared to the control group. At the second evaluation, significantly higher levels of IGF-I (p=0.003) were found in both the NBS and LD groups compared to controls; GHR mRNA expression had significantly increased (p=0.013) in LD patients in comparison with the first evaluation and was significantly higher in the NBS and LD groups than in controls. GHBP values had significantly increased (p=0.047) in the NBS group after one year of therapy compared to first visit levels and were significantly higher (p<0,0001) in the NBS and LD groups compared to controls.CONCLUSION: In our LD patients during childhood, we observed good auxological values and a GH/IGF-I axis function within normal range for the factor evaluated. However, earlier diagnosis through NBS might further minimize and prevent growth retardation, by reducing the duration of symptoms before treatment.",
author = "Sara Pagani and Elena Bozzola and Gloria Acquafredda and Vito Terlizzi and Valeria Raia and Fabio Majo and Alberto Villani and Mauro Bozzola",
note = "{\circledC} 2019 Marshfield Clinic.",
year = "2019",
month = "8",
day = "28",
doi = "10.3121/cmr.2019.1476",
language = "English",
journal = "Clinical Medicine and Research",
issn = "1539-4182",
publisher = "Marshfield Clinic",

}

TY - JOUR

T1 - GH-IGF1 Axis in Children with Cystic Fibrosis

AU - Pagani, Sara

AU - Bozzola, Elena

AU - Acquafredda, Gloria

AU - Terlizzi, Vito

AU - Raia, Valeria

AU - Majo, Fabio

AU - Villani, Alberto

AU - Bozzola, Mauro

N1 - © 2019 Marshfield Clinic.

PY - 2019/8/28

Y1 - 2019/8/28

N2 - OBJECTIVE: To verify whether growth hormone receptor gene expression plays a role in Cystic fibrosis (CF)children's growth, as a consequence of the chronic inflammatory condition and malnutrition.DESIGN: We enrolled forty-nine prepubertal patients (24 males and 25 females) affected by CF in a stable clinical condition, 19 of whom had been diagnosed through newborn screening and 30 following presentation of symptoms. Patients had no significant comorbidity affecting growth or CFTR (Cystic Fibrosis Transmembrane conductance Regulator)-related diabetes requiring insulin therapy. Blood was collected during two follow-up visits to measure IGF-I, GHBP and GH-R gene expression. Fifty-two healthy children, sex- and age-matched, were recruited as a control group.METHODS: In this study we compared BMI, height, weight, IGF-I, GHBP and GHR gene expression values (evaluated by Chemiluminescent Immunometric assay; ELISA and Real time PCR respectively) in CF patients diagnosed through NBS (New born screening), or by symptoms (Late Diagnosis (LD)) and in healthy controls.RESULTS: BMI increased significantly in patients between the time of diagnosis and check-ups (p<0.001) and particularly in the LD group, the median value was lower at diagnosis and significantly higher (p<0.001) at follow up visits compared to controls. At the initial evaluation, higher levels of IGF-I (not statistically significant) were found in both the NBS group and in the LD group compared to the control group. At the second evaluation, significantly higher levels of IGF-I (p=0.003) were found in both the NBS and LD groups compared to controls; GHR mRNA expression had significantly increased (p=0.013) in LD patients in comparison with the first evaluation and was significantly higher in the NBS and LD groups than in controls. GHBP values had significantly increased (p=0.047) in the NBS group after one year of therapy compared to first visit levels and were significantly higher (p<0,0001) in the NBS and LD groups compared to controls.CONCLUSION: In our LD patients during childhood, we observed good auxological values and a GH/IGF-I axis function within normal range for the factor evaluated. However, earlier diagnosis through NBS might further minimize and prevent growth retardation, by reducing the duration of symptoms before treatment.

AB - OBJECTIVE: To verify whether growth hormone receptor gene expression plays a role in Cystic fibrosis (CF)children's growth, as a consequence of the chronic inflammatory condition and malnutrition.DESIGN: We enrolled forty-nine prepubertal patients (24 males and 25 females) affected by CF in a stable clinical condition, 19 of whom had been diagnosed through newborn screening and 30 following presentation of symptoms. Patients had no significant comorbidity affecting growth or CFTR (Cystic Fibrosis Transmembrane conductance Regulator)-related diabetes requiring insulin therapy. Blood was collected during two follow-up visits to measure IGF-I, GHBP and GH-R gene expression. Fifty-two healthy children, sex- and age-matched, were recruited as a control group.METHODS: In this study we compared BMI, height, weight, IGF-I, GHBP and GHR gene expression values (evaluated by Chemiluminescent Immunometric assay; ELISA and Real time PCR respectively) in CF patients diagnosed through NBS (New born screening), or by symptoms (Late Diagnosis (LD)) and in healthy controls.RESULTS: BMI increased significantly in patients between the time of diagnosis and check-ups (p<0.001) and particularly in the LD group, the median value was lower at diagnosis and significantly higher (p<0.001) at follow up visits compared to controls. At the initial evaluation, higher levels of IGF-I (not statistically significant) were found in both the NBS group and in the LD group compared to the control group. At the second evaluation, significantly higher levels of IGF-I (p=0.003) were found in both the NBS and LD groups compared to controls; GHR mRNA expression had significantly increased (p=0.013) in LD patients in comparison with the first evaluation and was significantly higher in the NBS and LD groups than in controls. GHBP values had significantly increased (p=0.047) in the NBS group after one year of therapy compared to first visit levels and were significantly higher (p<0,0001) in the NBS and LD groups compared to controls.CONCLUSION: In our LD patients during childhood, we observed good auxological values and a GH/IGF-I axis function within normal range for the factor evaluated. However, earlier diagnosis through NBS might further minimize and prevent growth retardation, by reducing the duration of symptoms before treatment.

U2 - 10.3121/cmr.2019.1476

DO - 10.3121/cmr.2019.1476

M3 - Article

C2 - 31462537

JO - Clinical Medicine and Research

JF - Clinical Medicine and Research

SN - 1539-4182

ER -